# The Grieshaber-Bouyer Laboratory

![Team image](docs/assets/Team_Prof_Grieshaber_UKER.jpg)
(c) SIMOarts / Simone Kessler

# About
We are a systems immunology laboratory in the [Department of Internal Medicine 3 – Rheumatology and Immunology at Erlangen University Hospital](https://www.medizin3.uk-erlangen.de/en/).  
Our group investigates the mechanisms driving immune cell heterogeneity in tissues and inflammatory conditions and the links to disease variation across individuals. Our approach is characterized by a combination of high dimensional discovery in patient samples (in particular in the context of innovative therapies such as CAR-T cells) with in vitro systems, CRISPR-mediated genetic perturbations and murine models. We also develop novel analysis tools for high dimensional data.  
In published work, we demonstrated that neutrophils in homeostasis are organized a chronologically ordered main sequence, termed neutrotime. In experimental inflammation, neutrophils reach distinct polarization states driven by timepoint, tissue and stimulus.  
To apply this principle to human immune-mediated disease, we developed a method to jointly analyze murine and human transcriptomic data. Thereby, we identified a transcriptional program which characterizes neutrophils in the arthritic joint in both mice and humans. Functionally, this program was highly enriched for interferon gamma response genes, which we validated on the protein level and using in vitro models.  


# Team

## Principal Investigator

**Prof. Dr. med. Ricardo Grieshaber-Bouyer**  
Professor of Clinical Systems Immunology  
Head of the Clinical Trial Unit  
Director, Center of Systems Immunology (CSI) Erlangen [(FOCIS Center of Excellence)](https://www.focisnet.org/communities/fces/)

## Lab Members – Erlangen

**Dr. Kirill Anoshkin, PhD**  
Postdoctoral fellow

**Sebastian Böltz, MD**  
Physician scientist

**Laura Bucci, MD**  
Physician scientist

**Elaine Degen**  
Dr. med. candidate

**Dr. Panagiotis Garantziotis, PhD**  
Physician scientist

**Sanjukta Gubbi**  
Dr. rer. nat. candidate

**Dr. med. Melanie Hagen**  
Physician scientist  
Head of the Clinical Trial Unit

**Nicolas J. Nitsche**  
M.Sc. student

**Dr. rer. nat. Tobias Rothe**  
Postdoctoral fellow

**Peter Scheuerlein**  
Research technician

**Liang Zhang**  
Dr. rer. nat. candidate

## Lab Members – Heidelberg

**Dr. med. Tarik Exner**  
Postdoctoral fellow/PhD candidate in the [HBIGS MD/PhD program](http://www.hbigs.uni-heidelberg.de)

**Frederic S. Pohl**  
Dr. med. candidate


## Alumni

**Dr. med. Cassian M. Afting**  
Rotation student  
Now [HBIGS fellow](http://www.hbigs.uni-heidelberg.de) in [Prof. Dr. Joachim Wittbrodt's Lab](https://www.cos.uni-heidelberg.de/en/research-groups/developmental-biologyphysiology)

**Selina Belghalem**  
Research technician

**Dr. med. Frank Y. Huang**  
Dr. med. candidate and [Boehringer Ingelheim Fonds fellow](https://www.bifonds.de/index.html)  
Now [HBIGS fellow](http://www.hbigs.uni-heidelberg.de) in [Prof. Dr. Andreas Trumpp's Lab](https://www.hi-stem.de/research-trumpp)

**Mareike de Groot**  
Dr. med. candidate 
[Peter-Scriba fellow (German Society of Internal Medicine)](https://www.dgim.de/en/the-gsim/)

**Nicolaj S. Hackert**  
Dr. med. candidate  
[Boehringer Ingelheim Fonds fellow](https://www.bifonds.de/index.html)

**Niklas R. Junker**  
Dr. med. candidate

**Sophie E. Leonhardt**  
Research technician  
Now Medical Student at [Saarland University](https://www.uni-saarland.de/en/home.html)

**Görkem Osmanusta**  
Dr. med. candidate

**Felix A. Radtke**  
Dr. med. candidate and [Boehringer Ingelheim Fonds fellow](https://www.bifonds.de/index.html)  
Now DPhil Student in [Professor Paresh Vyas' Group](https://www.imm.ox.ac.uk/research/research-groups/vyas-group-normal-and-malignant-haematopoiesis-lab) at [University of Oxford](https://www.ox.ac.uk)

**Julia T. Schnell**  
Dr. med. candidate  
[PROMOS fellow (German Academic Exchange Service, DAAD)](https://www.daad.de/de/)

## Open Positions
We welcome applications by enthusiasts across wet and dry immunology, bioinformatics and data science enthusiasts!

# Publications

### 2024

[Bispecific T cell engager therapy for refractory rheumatoid arthritis.](https://www.nature.com/articles/s41591-024-02964-1)  
Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D’Agostino MA, Schett G, **Grieshaber-Bouyer R**
_Nature Medicine_ 2024

[CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up](https://www.nejm.org/doi/full/10.1056/NEJMoa2308917)  
Müller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, Rothe T, Minopoulou I, Tur C, Knitza J, Kharboutli S, Kretschmann S, Vasova I, Spoerl S, Reimann H, Munoz L, Gerlach RG, Schäfer S, **Grieshaber-Bouyer R**, Korganow AS, Farge-Bancel D, Mougiakakos D, Bozec A, Winkler T, Krönke G, Mackensen A, Schett G  
_New Engl J Med_ 2024

### 2023

[Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts](https://doi.org/10.1038/s41467-023-43573-9)  
Hackert NS\*, Radtke FA\*, Exner T\*, Lorenz HM, Mueller-Tidow C, Nigrovic PA, Wabnitz G, **Grieshaber-Bouyer R**  
_Nature Communications_ 2023

[CD19 CAR-T cell treatment: Unraveling the role of B cells in Systemic Lupus Erythematosus](https://acrjournals.onlinelibrary.wiley.com/doi/abs/10.1002/art.42784)  
Taubmann J, Müller F, Mutlu MY, Völkl S, Aigner M, Bozec A, Mackensen A, **Grieshaber-Bouyer R\***, Schett G\*  
_Arthritis Rheumatol_ 2023

[Distinct Functional States of Neutrophils by Actin Disassembly and NF-kB/STAT3 Signaling](https://doi.org/10.1101/2023.07.14.548975)  
Heineken N, Schumacher JC, Exner T, Neuenfeldt F, Habicht J, Kahlich F, Platzer H, Merle U, Renkawitz T, Samstag Y, **Grieshaber-Bouyer R**, Autenrieth S, Wabnitz GH  
_bioRxiv_ 2023

### 2022

[Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint](https://doi.org/10.1136/annrheumdis-2021-221866)  
**Grieshaber-Bouyer R<sup>#</sup>**, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, Karimizadeh E, Brennan J, Schettini J, Jonsson AH, Rao DA, Henderson LA, Mueller-Tidow C, Lorenz HM, Wabnitz G, Lederer JA, Hadjipanayis A, Nigrovic PA<sup>#</sup>. <sup>#</sup>Corresponding authors  
_Ann Rheum Dis_ 2022

[Inflammation induces pro-NETotic neutrophils via TNFR2 signaling](https://doi.org/10.1016/j.celrep.2022.110710)  
Neuenfeldt F\*, Schumacher JC\*, **Grieshaber-Bouyer R**, Habicht J, Schröder-Braunstein J, Gauss A, Niesler B, Heineken N, Dalpke A, Gaida MM, Giese T, Meuer S, Samstag Y, Wabnitz G  
_Cell Reports_ 2022

[Neutrophil transit time and localization within the megakaryocyte define morphologically distinct forms of emperipolesis](https://doi.org/10.1182/bloodadvances.2021005097)  
Huang FY\*, Cunin P\*, Radtke FA, Darbousset R, **Grieshaber-Bouyer R**, Nigrovic PA  
_Blood Advances_ 2022

### 2021

[The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments](https://doi.org/10.1038/s41467-021-22973-9)  
**Grieshaber-Bouyer R**, Radtke FA, Cunin P, Stifano G, Levescot A, Vijaykumar B, Nelson-Maney N, Blaustein RB, Monach PA, Nigrovic PA; Immunological Genome Project Consortium  
_Nature Communications_ 2021

[JAK inhibition prevents the induction of pro-inflammatory HLA-DR+ CD90+ RA synovial fibroblasts by IFNɣ](https://doi.org/10.1002/art.41958)  
Zhao S, **Grieshaber-Bouyer R**, Rao DA, Kolb P, Chen H, Andreeva I, Tretter T, Lorenz HM, Watzl C, Wabnitz G, Tykocinski LO, Merkt W  
_Arthritis Rheumatol_ 2021

[Arthritis flares mediated by tissue-resident memory T cells in the joint](https://doi.org/10.1016/j.celrep.2021.109902)  
Chang MH\*, Levescot A\*, Nelson-Maney N, Blaustein RB, Winden KD, Morris A, Wactor A, Balu S, **Grieshaber-Bouyer R**, Wei K, Henderson LA, Iwakura Y, Clark RA, Rao DA, Fuhlbrigge RC<sup>#</sup>, Nigrovic PA<sup>#</sup>  
_Cell Reports_ 2021

[IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis](https://doi.org/10.1172/JCI141008)  
Levescot A, Chang MH, Schnell J, Nelson-Maney N, Yan J, Martínez-Bonet M, **Grieshaber-Bouyer R**, Lee PY, Wei K, Blaustein RB, Morris A, Wactor A, Iwakura Y, Lederer JA, Rao DA, Charles JF, Nigrovic PA  
_J Clin Invest_ 2021

[Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes](https://doi.org/10.1038/s41590-020-00836-7)  
Kiner E, Willie E, Vijaykumar B, Chowdhary K, Schmutz H, Chandler J, Schnell A, Thakore PI, LeGros G, Mostafavi S, Mathis D, Benoist C; Immunological Genome Project Consortium [consortium including **Grieshaber-Bouyer R**]  
_Nature Immunology_ 2021

[A microRNA expression and regulatory element activity atlas of the mouse immune system](https://doi.org/10.1038/s41590-021-00944-y)  
Rose SA, Wroblewska A, Dhainaut M, Yoshida H, Shaffer JM, Bektesevic A, Ben-Zvi B, Rhoads A, Kim EY, Yu B, Lavin Y, Merad M, Buenrostro JD, Brown BD; Immunological Genome Consortium. [consortium including **Grieshaber-Bouyer R**]  
_Nature Immunology_ 2021


### 2020

[ImmGen at 15](https://doi.org/10.1038/s41590-020-0687-4)  
Immunological Genome Project Consortium [consortium including **Grieshaber-Bouyer R**]  
_Nature Immunology_ 2020

[Biosimilars – Opportunities and Risks](https://doi.org/10.1007/s00108-020-00784-2)  
**Grieshaber-Bouyer R<sup>#</sup>**, Lorenz HM  
_Internist (Berl)_ 2020

### 2019

[Divergent mononuclear cell participation and cytokine release profiles define hip and knee osteoarthritis](https://doi.org/10.3390/jcm8101631)  
**Grieshaber-Bouyer R\***, Kämmerer T\*, Rosshirt N, Nees T, Koniezke P, Hagmann S, Tripel E, Schiltenwolf M, Kirsch J, Moradi B  
_J Clin Med_ 2019

[Neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease](https://doi.org/10.3389/fimmu.2019.00346)  
**Grieshaber-Bouyer R**, Nigrovic PA  
_Front Immunol_ 2019


### 2018

[Maestro endothelium conducts the neutrophils](https://doi.org/10.1182/blood-2018-09-872085)  
**Grieshaber-Bouyer R**, Nigrovic PA  
_Blood_ 2018


### 2017

[CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation](https://doi.org/10.1182/blood-2017-03-768507)  
Bai M\*, **Grieshaber-Bouyer R\***, Wang JX, Schmider AB, Wilson ZS, Zeng L, Halyabar O, Godin MD, Nguyen HN, Levescot A, Cunin P, Lefort CT, Soberman RJ, Nigrovic PA  
_Blood_ 2017

[Arthroscopic Repair of Recurrent Posterior Shoulder Subluxation after Total Shoulder Arthroplasty](https://doi.org/10.2106/JBJS.CC.17.00048)  
**Grieshaber-Bouyer R<sup>#</sup>**, Gerber C  
_JBJS Case Connect_ 2017


# In The News

[How a “date” between immune cells makes rheumatism disappear
](https://www.bionity.com/en/news/1183376/how-a-date-between-immune-cells-makes-rheumatism-disappear.html)  
Bionity, May 06, 2024

[Artrite reumatoide, l’impiego di anticorpi monoclonali rivoluziona la terapia dei casi gravi
](https://www.insalutenews.it/in-salute/artrite-reumatoide-limpiego-di-anticorpi-monoclonali-rivoluziona-la-terapia-dei-casi-gravi/)  
insalute news, May 02, 2024

[FAU team develops new approach for treating autoimmune diseases 
](https://www.fau.eu/2024/05/02/news/fau-team-develops-new-approach-for-treating-autoimmune-diseases/)  
Friedrich-Alexander-Universität Erlangen-Nürnberg, May 02, 2024

[Clinical report: Academic trials signal autoimmune opportunities for T cell engagers
](https://www.biocentury.com/article/652286/clinical-report-academic-trials-signal-autoimmune-opportunities-for-t-cell-engagers)  
BioCentury, May 01, 2024

[Rheuma: T- trifft B-Zelle
](https://www.mtdialog.de/news/artikel/rheuma-t-gegen-b-zelle)  
MT im Dialog, April 30, 2024

[Wie ein „Date“ von Immunzellen Rheuma verschwinden lässt
](https://idw-online.de/de/news832692)  
Informationsdienst Wissenschaft e.V., April 26, 2024

[Rheuma schon vor dem Ausbruch verhindern?
](https://www.tagesschau.de/wissen/gesundheit/rheuma-forschung-100.html)  
Tagesschau, March 12, 2024

[Studie: Rheuma kann schon vor dem Ausbruch verhindert werden
](https://www.br.de/nachrichten/wissen/studie-rheuma-kann-schon-vor-dem-ausbruch-verhindert-werden,U5nSoUu)  
Bayerischer Rundfunk, March 05, 2024

[Central inflammation system discovered
](https://www.msn.com/en-us/health/other/central-inflammation-system-discovered/ar-BB1hyrmG)  
MSN news, January 31, 2024

[Super code cracked: Central inflammation system discovered
](https://www.fau.eu/2024/01/31/news/research/super-code-cracked-central-inflammation-system-discovered/)  
Friedrich-Alexander-Universität Erlangen-Nürnberg, January 31, 2024

[Neu an der Uni: Prof. Dr. med. Ricardo Grieshaber-Bouyer
](https://www.fau.de/2023/10/news/neu-an-der-uni-prof-dr-med-ricardo-grieshaber-bouyer-rodrigues/)  
Friedrich-Alexander-Universität Erlangen-Nürnberg, October 01, 2023

[Personalized Treatment Recommendations for Spondyloarthropathies](https://zpm-verbund.de/de/forschung/projekte/19-personalisierte-therapieempfehlung-bei-spondyloarthritiden)  
Centers for Personalized Medicine (ZPM), 2022

[Tracking neutrophil development along a continuous spectrum with single cell analysis](https://www.10xgenomics.com/blog/tracking-neutrophil-development-along-a-continuous-spectrum-with-single-cell-analysis)  
Jeanene Swanson, 10X Genomics, July 23, 2021

[INNATE IMMUNITY IN THE FOCUS OF HEIDELBERG's RHEUMATOLOGY  
Research Award by the German Society for Rheumatology (DGRh)](https://www.klinikum.uni-heidelberg.de/newsroom/angeborene-immunitaet-im-fokus-der-heidelberger-rheumatologie/)    
Heidelberg University Hospital, October 19, 2020


# Teaching

We are integrated in the [iImmune](https://www.iimmune.nat.fau.de/) Integrated Immunology M.Sc. programme @FAU Erlangen

# Directions

Erlangen:  
Glückstraße 4A  
91054 Erlangen

Heidelberg:  
Institute for Immunology  
Im Neuenheimer Feld 305  
69120 Heidelberg

[Data processing policy (Datenschutzerklärung)](https://www.heidelberg-university-hospital.com/data-protection-policy)  
[Imprint (Impressum)](https://www.heidelberg-university-hospital.com/imprint)
